S.A.M. Clinical Research Center is a clinical research site located in San Antonio, Texas, United States 78229.
Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.
S.A.M. Clinical Research Center has participated in 11 clinical trials.
Therapeutic areas: Type 2 Diabetes Mellitus, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Type 2.
Sponsors: AstraZeneca, Bristol-Myers Squibb, Pfizer's Upjohn has merged with Mylan to form Viatris Inc..
Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
S.A.M. Clinical Research Center has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
S.A.M. Clinical Research Center has 11 clinical trials on record. Their work covers Type 2 Diabetes Mellitus, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Type 2.
Yes — S.A.M. Clinical Research Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.